Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: Frederick Langford who wrote (51346)	12/27/1999 1:03:00 PM
From: crimson	Read Replies (2) \| Respond to of 108040

I like BIOM for biotech, but don't own any.

To: Frederick Langford who wrote (51346)	12/27/1999 1:06:00 PM
From: Triffin	Read Replies (3) \| Respond to of 108040

Fred .. Biotech .. Look at the BBH it's a unit trust like QQQ or HHH ... BBHs hold 30 of the top biotech companies ... Merrily Lynch BioTech Holders is what it's called trades on the ASE .. Also like CRA and HGSI in the 'genome' space .. Jim in CT ..

To: Frederick Langford who wrote (51346)	12/27/1999 1:09:00 PM
From: If only I'd held	Respond to of 108040

If you don't own GENE yet, you should. Right now would be a decent time to begin your position.

To: Frederick Langford who wrote (51346)	12/27/1999 2:21:00 PM
From: Dotty	Read Replies (1) \| Respond to of 108040

Re:Biotechs....Protein Design powers biotech group By Debra McGarry, CBS MarketWatch Last Update: 7:34 PM ET Dec 22, 1999 Screamers Biotech Report Movers & Shakers ¥ ¥ Sector Indexes ¥ Market Snapshot NEW YORK (CBS.MW) -- Investors piled into biotech stocks Wednesday, driving the sector index up 6.3 percent amid positive press and year-end buying. Today on CBS MarketWatch Nasdaq nears 4000 Bell Atlantic to offer long-distance service Corel stock on the rocks after warning Microsoft CFO steps aside StockWatch: Undervalued incubators More top stories... CBS MarketWatch Columns Updated: 12/22/99 5:08:02 PMÊETThe Amex Biotech Index's ($btk) gain follows a 7 percent jump Tuesday. Protein Design Labs (pdli), one component in the index, advanced 16 percent, or 8 5/8 to close at 63 1/8. Warburg Dillon Read analyst Michael Wood initiated coverage of the drug developer with a "buy" rating and set a 12-month price target of $74. Protein Design develops human and humanized antibodies and other potential drugs to prevent or treat certain disease conditions. The company's SMART humanized antibody technology uses genetic engineering and computer modeling to generate humanized antibodies for use as therapeutic agents. In a research note, Warburg forecast Protein's total revenue for 1999-2003 at $27 million, $37 million, $53 million, $125 million and $172 million. The investment firm also said Protein Design's Zenapax drug may become an important revenue generator for the company in the future. "Biotech stocks are moving into the spotlight with the evolution of companies specializing in the human genomic industry," said Matthew Geller, analyst at CIBC World Markets. A certain amount of year-end window dressing also contributed to the recent buying, Geller noted. Other stocks that helped to lift the group: Gilead Sciences (gild) rose 4 13/16, or 12 percent, to 45 7/16; Chiron (chir) gained 5 1/16 to 42 and COR Therapeutics (corr) added 3/8 to 22 7/16. On Tuesday Gilead admitted infringing on Chiron's U.S. hepatitis C virus protease patens and agreed to pay an unspecified sum and other terms to settle the case. See press release. The Nasdaq Biotech Index ($ixbt) powered up 5 percent, led by Genome Therapeutics (gene), which soared 50 percent after it announced a genomics-based alliance with Wyeth-Ayerst, an American Home Products (ahp) division. American Home shares dipped 9/16 to 40. See Screamers.

To: Frederick Langford who wrote (51346)	12/27/1999 2:40:00 PM
From: Kevin McKenzie	Read Replies (3) \| Respond to of 108040

Fred, Here are some small cap biotech stocks with recent good momentum. I haven't researched any yet, just a list to start with: Symbol Name Trend Price #Shrs (millions) (KNDL) KENDLE INTL INC UP 10.875 11.4 (NZYM) SYNTHETECH INC UP 3.625 14.2 (CLTX) COLLATERAL THERAPEUTICS INC DN 15.375 12.9 (TRGNY) TRANSGENE S A DN 8.875 2.1 (ONXX) ONYX PHARMACEUTICALS INC DN 7.875 11.5 (BTX) BIOTIME INC DN 9.500 10.8 (AMRI) ALBANY MOLECULAR RESH INC UP 30.000 14.5 (EPTO) EPITOPE INC UP 6.062 14.1 (DCRN) DIACRIN INC UP 6.500 14.3 (CNTBY) CANTAB PHARMACEUTICALS PLC UP 9.500 13.7 (VITX) V I TECHNOLOGIES INC UP 6.062 12.5 (SNAP) SYNAPTIC PHARMACEUTICAL CORP UP 6.875 10.7 (CCHE) CLINICHEM DEV INC UP 8.937 2.7 (EMBX) EMBREX INC UP 12.250 7.9 (SPRX) SPECTRX INC UP 11.250 8.0 (LJLB) LJL BIOSYSTEMS INC UP 7.375 12.6 (ARQL) ARQULE INC UP 8.312 12.8 (MMP) MAXIM PHARMACEUTICALS INC UP 18.937 10.2 (NEOT) NEOTHERAPEUTICS INC DN 11.812 7.9 (DOR) ENDOREX CORP UP 2.875 10.3 (MCDE) MICROCIDE PHARMCTCLS INC UP 7.312 11.1 (BREL) BIORELIANCE CORP DN 6.750 7.9 (FOCL) FOCAL INC DN 4.125 13.4 (ALXN) ALEXION PHARMACEUTICALS INC UP 24.625 11.3 (LYNX) LYNX THERAPEUTICS INC UP 33.187 11.2